Headache & Migraine
Migraine Briefs
Galcanezumab shows promise in a real-life cohort of patients with migraine
Migraine Briefs
Fremanezumab beneficial for patients with migraine and comorbid depression
Migraine Briefs
Migraine: Repeated transcranial direct current stimulation effectively reduces pain intensity
Migraine Briefs
Erenumab shows long-term promise in episodic migraine patients with prior treatment failures
Migraine Briefs
Chronic migraine: Efficacy and safety of CGRP slightly better than botulinum toxin
Migraine Briefs
Erenumab reduces migraine attacks and not just migraine days
Conference Coverage
Moving more, sitting less vital for migraine patients
Encouraging patients with migraine to regularly physically exercise is important to managing their symptoms and overall health, but so is simply...
Conference Coverage
Ubrogepant effective for acute migraine even with preventive monoclonal antibody therapy
Despite sharing similar mechanisms, the use of ubrogepant for acute migraine attacks in people already taking CGRP-targeting monoclonal antibody...
Conference Coverage
Migraine linked to more COVID-19 infections, symptoms but less health care utilization
People with migraine are either more susceptible to contracting COVID-19, or they may be more sensitive to the development of symptoms once COVID-...
Conference Coverage
Chronic headache pain in veterans linked to suicide attempts
U.S. veterans with chronic headache pain had an increased risk of attempting suicide compared with vets with chronic neck or back pain,...